For those who think all is just well in Norway, think again. Certain people will always find (invent) a BPS explanation no matter what the findings are.
Here they have a genetic variation correlating to CFS prognosis. As the the faithful members of the "church of BPS" they are, they couple their genetic findings to mental health, and argue that therefore mental health is a maintaining factor of CFS! These guys are supposed to be the "experts in Norway" apart from Fluge &Mella.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140883
Here they have a genetic variation correlating to CFS prognosis. As the the faithful members of the "church of BPS" they are, they couple their genetic findings to mental health, and argue that therefore mental health is a maintaining factor of CFS! These guys are supposed to be the "experts in Norway" apart from Fluge &Mella.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140883
Abstract
Earlier studies have shown that genetic variability in the SLC6A4 gene encoding the serotonin transporter (5-HTT) may be important for the re-uptake of serotonin (5-HT) in the central nervous system. In the present study we investigated how the 5-HTT genotype i.e. the short (S) versus long (L) 5-HTTLPR allele and the SNP rs25531 A > G affect the physical and psychosocial functioning in patients with chronic fatigue syndrome (CFS). All 120 patients were recruited from The Department of Paediatrics at Oslo University Hospital, Norway, a national referral center for young CFS patients (12-18 years). Main outcomes were number of steps per day obtained by an accelerometer and disability scored by the Functional Disability Inventory (FDI). Patients with the 5-HTT SS or SLG genotype had a significantly lower number of steps per day than patients with the 5-HTT LALG, SLA or LALA genotype. Patients with the 5-HTT SS or SLG genotype also had a significantly higher FDI score than patients with the 5-HTT LALG, SLA or LALA genotype. Thus, CFS patients with the 5-HTT SS or SLG genotype had worse 30 weeks outcome than CFS patients with the 5-HTT LALG, SLA or LALA genotype. The present study suggests that the 5-HTT genotype may be a factor that contributes to maintenance of CFS.
Depending on the localization of the 5-HTT relative to the 5-HT autoreceptors, this might decrease or increase the 5-HT signaling in the CNS. Hence, genetic variability in the gene encoding the 5-HTT has consequences that may be associated with mental health. Previous data have demonstrated that the S allele of the 5-HTTLPR may be linked to depression [22,23] and suicidality in relation to stressful life events [22]. Earlier studies also suggest that the S allele of the 5-HTTLPR is associated with neurocognitive impairment [24] and bipolar disorders [25]. In addition, variation in the 5-HTT gene SLC6A4 may modulate attention to threat [26], anxiety, negative affect and fear [10–12]. Moreover, the SS and SLG genotype seems to be associated with higher neuroticism [11], and a more serious symptomatic profile in patients who suffers from posttraumatic stress disorders [10]. Ultimately, it has also been suggested that the 5-HTT SS and SLG genotype may be associated with increased neuroplasticity making individuals more susceptible to environmental influences [13]. Hence, psychosocial aspects, bullying and stressful life events may have a more pronounced impact on adolescents with the 5-HTT SS and SLG genotype than other individuals. These data, together with the observations of the present study, indicate that the 5-HTT SS and SLG genotype may be a factor that contributes to the maintenance of CFS.